SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001521536-13-000747
Filing Date
2013-08-30
Accepted
2013-08-30 17:22:49
Documents
5
Period of Report
2013-08-26
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1101239_8k-biozone.htm 8-K 29152
2 FORM OF SECURITIES PURCHASE AGREEMENT q1101239_ex10-1.htm EX-10.1 164820
3 FORM OF NOTE q1101239_ex10-2.htm EX-10.2 46298
4 FORM OF WARRANT q1101239_ex10-3.htm EX-10.3 116373
5 SECURITY AGREEMENT LETTER q1101239_ex10-4.htm EX-10.4 15600
  Complete submission text file 0001521536-13-000747.txt   373476
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 131073116
SIC: 2834 Pharmaceutical Preparations